Rights and permissions
About this article
Cite this article
Anagrelide: controls thrombocytosis in patients with chronic myeloproliferative disease. Inpharma Wkly. 639, 5 (1988). https://doi.org/10.1007/BF03308344
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03308344